41 related articles for article (PubMed ID: 38605344)
21. Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development.
Nam SY; Park BJ; Nam JH; Kook MC
Gastrointest Endosc; 2019 Sep; 90(3):448-456.e1. PubMed ID: 31034810
[TBL] [Abstract][Full Text] [Related]
22. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
23. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
Choi YJ; Lee DH; Han KD; Shin CM; Kim N
Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
[TBL] [Abstract][Full Text] [Related]
24. Statins use and cancer: an update.
Zaleska M; Mozenska O; Bil J
Future Oncol; 2018 Jun; 14(15):1497-1509. PubMed ID: 29722274
[TBL] [Abstract][Full Text] [Related]
25. Adiposity and cancer at major anatomical sites: umbrella review of the literature.
Kyrgiou M; Kalliala I; Markozannes G; Gunter MJ; Paraskevaidis E; Gabra H; Martin-Hirsch P; Tsilidis KK
BMJ; 2017 Feb; 356():j477. PubMed ID: 28246088
[No Abstract] [Full Text] [Related]
26. [A case-control study on the association between serum lipid level and the risk of breast cancer].
Wei LJ; Zhang C; Zhang H; Wei X; Li SX; Liu JT; Ren XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1091-1095. PubMed ID: 28057114
[No Abstract] [Full Text] [Related]
27. Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population.
Kang R; Li P; Wang T; Li X; Wei Z; Zhang Z; Zhong L; Cao L; Heckman MG; Zhang YW; Xu H; Huang C; Bu G; Chen XF
Sci Rep; 2016 Jan; 6():19930. PubMed ID: 26817942
[TBL] [Abstract][Full Text] [Related]
28. Cancer statistics in China, 2015.
Chen W; Zheng R; Baade PD; Zhang S; Zeng H; Bray F; Jemal A; Yu XQ; He J
CA Cancer J Clin; 2016; 66(2):115-32. PubMed ID: 26808342
[TBL] [Abstract][Full Text] [Related]
29. Antioxidant properties of HDL.
Soran H; Schofield JD; Durrington PN
Front Pharmacol; 2015; 6():222. PubMed ID: 26528181
[TBL] [Abstract][Full Text] [Related]
30. Effects of Helicobacter pylori infection and its eradication on lipid profiles and cardiovascular diseases.
Nam SY; Ryu KH; Park BJ; Park S
Helicobacter; 2015 Apr; 20(2):125-32. PubMed ID: 25382033
[TBL] [Abstract][Full Text] [Related]
31. Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.
Bibi S; Arslanhan MD; Langenfeld F; Jeanningros S; Cerny-Reiterer S; Hadzijusufovic E; Tchertanov L; Moriggl R; Valent P; Arock M
Haematologica; 2014 Mar; 99(3):417-29. PubMed ID: 24598853
[TBL] [Abstract][Full Text] [Related]
32. Impact of metabolic syndrome on oncologic outcome after radical gastrectomy for gastric cancer.
Kim EH; Lee H; Chung H; Park JC; Shin SK; Lee SK; Hyung WJ; Lee YC; Noh SH
Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):372-8. PubMed ID: 24485596
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of obesity-induced gastrointestinal neoplasia.
Alemán JO; Eusebi LH; Ricciardiello L; Patidar K; Sanyal AJ; Holt PR
Gastroenterology; 2014 Feb; 146(2):357-373. PubMed ID: 24315827
[TBL] [Abstract][Full Text] [Related]
34. Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic Syndrome and Cancer Project (Me-Can).
Lindkvist B; Almquist M; Bjørge T; Stocks T; Borena W; Johansen D; Hallmans G; Engeland A; Nagel G; Jonsson H; Selmer R; Diem G; Häggström C; Tretli S; Stattin P; Manjer J
Cancer Causes Control; 2013 Jan; 24(1):107-16. PubMed ID: 23149498
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas.
Campos B; Centner FS; Bermejo JL; Ali R; Dorsch K; Wan F; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Burhenne J; Herold-Mende C
Am J Pathol; 2011 May; 178(5):1953-64. PubMed ID: 21514413
[TBL] [Abstract][Full Text] [Related]
36. The role of cholesterol in prostate cancer.
Hager MH; Solomon KR; Freeman MR
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):379-85. PubMed ID: 16778565
[TBL] [Abstract][Full Text] [Related]
37. Effect of Oat (Avena sativa L.) Consumption on Lipid Profile With Focus on Triglycerides and High-density Lipoprotein Cholesterol (HDL-C): An Updated Systematic Review.
Amerizadeh A; Ghaheh HS; Vaseghi G; Farajzadegan Z; Asgary S
Curr Probl Cardiol; 2023 Jul; 48(7):101153. PubMed ID: 35192870
[TBL] [Abstract][Full Text] [Related]
38. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers of lipid metabolism in gastric cancer: a case control study.
Li F; Dou J; Wei L; Li S; Liu J
BMC Cancer; 2024 Apr; 24(1):455. PubMed ID: 38605344
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
